New eczema pill shows promise in early safety trial
Symptom relief
Completed
This early-stage trial tested a new oral drug called ENV-294 in 9 adults with moderate-to-severe atopic dermatitis (eczema). Participants took the drug once daily for 28 days and had weekly checkups. The main goal was to see if the drug is safe and tolerable, while also looking f…
Phase: PHASE1 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC